WASHINGTON, D.C. (April 4, 2014)—Michael Dixon, president and CEO of UNeMed Corporation, is scheduled to testify on behalf of the University of Nebraska before a congressional committee next week in Washington D.C.
Dixon, who oversees intellectual property commercialization efforts for research developed at the University of Nebraska Medical Center, was invited to provide testimony to the Subcommittee on Commerce, Manufacturing and Trade by U.S. Rep. Lee Terry of Nebraska, the subcommittee chairman.
The hearing, “Trolling for a Solution: Ending Abusive Patent Demand Letters,” is scheduled for Tuesday, April 8, at 9 a.m. The committee is expected to discuss the practice of so-called “patent trolls,” which are often accused of targeting small businesses with patent demand letters that threaten financial or legal action.
Dixon’s testimony is expected to address the merits of university research and commercialization efforts, and the potential impact that new legislation may have.
Additional information about the hearing, including video coverage, will be available through the committee website. C-Span coverage of the hearing has not yet been determined.
